People at the conference table
Current topic: Current issues

Asset Publisher

null Start-up of Borealis, Finland’s sixth biobank

Start-up of Borealis, Finland’s sixth biobank

14.7.2015 10:14 / News

On 10 July 2015, the National Authority for Welfare and Health (Valvira) entered the Northern Finland Biobank Borealis into the national biobank register. Borealis is Finland’s sixth official biobank and is owned by the Northern Ostrobothnia Hospital District (PPSHP). Borealis promotes biomedical, clinical, translational and health science research, as well as product development, and also supports the development of diagnostics and patient medical care within the special responsibility area of Oulu University Hospital (OYS-ERVA). The Biobank is headed by Docent Saila Kauppila DMedSc. Borealis will gradually collect around 150,000 tissue, blood and other samples each year from patients treated by OYS-ERVA and who give the biobank their consent for samples to be taken for research purposes. In addition, the biobank will assume responsibility for existing sample collections, which include, for example, samples taken earlier from healthcare patients undergoing routine diagnostics and medical treatment. Following scrutiny of the biobank’s operational plans, the National Committee on Medical Research Ethics (TUKIJA) has taken the view that the biobank meets the relevant privacy and self-determination requirements for donors and is considered otherwise ethically robust. The competent authorities provided by law are Valvira and the Office of the Data Protection Ombudsman, who together oversee that biobank activities are in compliance with the requirements laid down by law, regulations and guidelines.

For further information, please contact:

Sandra Liede, Senior Officer, Legal Affairs, tel: +358 (0)295 209 501 or biopankit@valvira.fi